Evidence map›Paper›PMID 40572610›Full record

ArticleMolecules (Basel, Switzerland)2025

Validated UHPLC Methods for Melatonin Quantification Reveal Regulatory Violations in EU Online Dietary Supplements Commerce.

Celine Vanhee, Cloë Degrève, Niels Boschmans, Yasmina Naïmi, Michael Canfyn, Eric Deconinck, Marie Willocx

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Celine VanheeService Medicines and Health Products, Scientific Direction of Chemical and Physical Health Risks, Sciensano, J. Wytsmanstraat 14, B-1050 Brussels, Belgium.ORCID 0000-0002-6634-3706
Cloë DegrèveService Medicines and Health Products, Scientific Direction of Chemical and Physical Health Risks, Sciensano, J. Wytsmanstraat 14, B-1050 Brussels, Belgium.ORCID 0009-0008-0465-4569
Niels BoschmansService Medicines and Health Products, Scientific Direction of Chemical and Physical Health Risks, Sciensano, J. Wytsmanstraat 14, B-1050 Brussels, Belgium.
Yasmina NaïmiService Medicines and Health Products, Scientific Direction of Chemical and Physical Health Risks, Sciensano, J. Wytsmanstraat 14, B-1050 Brussels, Belgium.
Michael CanfynService Medicines and Health Products, Scientific Direction of Chemical and Physical Health Risks, Sciensano, J. Wytsmanstraat 14, B-1050 Brussels, Belgium.
Eric DeconinckService Medicines and Health Products, Scientific Direction of Chemical and Physical Health Risks, Sciensano, J. Wytsmanstraat 14, B-1050 Brussels, Belgium.ORCID 0000-0001-6980-6684
Marie WillocxService Medicines and Health Products, Scientific Direction of Chemical and Physical Health Risks, Sciensano, J. Wytsmanstraat 14, B-1050 Brussels, Belgium.ORCID 0000-0003-4739-7511

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The global sleep aids market has grown significantly due to rising stress and increased awareness of sleep's importance. Melatonin, available in the EU as a prescription or over-the-counter medicine, depending on the country, is also permitted in dietary supplements with country-specific limits. Recent reports indicate concerning levels of excessive melatonin in EU dietary supplements, necessitating accurate quantification methods. We developed and validated, by applying accuracy profiles, ISO17025-compliant, rapid ultra-high performance liquid chromatography (UHPLC) methodologies coupled with either diode array detection (DAD) or high-resolution accurate mass spectrometry (HRAM MS). The cost-effective UHPLC-DAD method is suitable for medicines and most dietary supplements, except those more complex herbal matrices containing passionflower, hop, hemp, lime tree or lavender or their extracts, where UHPLC-HRAM MS is recommended due to selectivity issues of the DAD methodology. To demonstrate the applicability, we analyzed 50 dietary supplements claiming to contain melatonin-25 from legal supply chains and 25 from suspicious sources claiming therapeutic melatonin content. Our findings confirmed previous reports of high melatonin content in online products, especially when purchased through rogue internet pharmacies. Moreover, 12% of legal supply chain samples violated current legislation through unauthorized health claims or contained at least triple the melatonin amount permitted in Belgium. This research provides reliable analytical methods for regulatory bodies and confirms the circulation of non-compliant melatonin-containing dietary supplements in the EU market, even in the legal supply chain.

Indexed as

Dietary SupplementsMelatoninChromatography, High Pressure LiquidCommerceEuropean UnionHumansMass SpectrometryMelatoninanalytical chemistrychromatographydietary supplementsmass spectrometrymethod validationpublic healthquality control

Identifiers

PMID40572610
PMCPMC12196456

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.